P2Y12 H2 Haplotype Is Associated with Peripheral Arterial Disease: A Case-Control Study

Circulation

Volumn 108, Issue 24, 2003, Pages 2971-2973

  Fontana, Pierre ^a,b   Gaussem, Pascale ^a,b   Aiach, Martine ^a,b   Fiessinger, Jean Noël ^a,b   Emmerich, Joseph ^a,b   Reny, Jean Luc ^a,b  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Arteries; Atherosclerosis; Peripheral vascular disease; Platelets; Thrombosis

Indexed keywords

PURINE P2Y12 RECEPTOR; MEMBRANE PROTEIN; P2RY12 PROTEIN, HUMAN; PURINE P2 RECEPTOR;

ADULT; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOCYTE; THROMBOCYTE AGGREGATION; AGED; ARTERIOSCLEROSIS; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

AGED; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, PURINERGIC P2;

EID: 0346365089     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000106904.80795.35     Document Type: Article

References (12)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost. 2001;86:222-232.
3. Conley PB, Delaney SM. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol. 2003;10:333-338.
4. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-1339.
5. Hollopeter G, Jantzen HM, Vincent D. et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001;409:202-207.
6. Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation. 2003;108:989-995.
7. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-1264.
8. Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000;7:284-289.
9. Arnaud E, Nicaud V, Poirier O, et al. Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol. 2000;20:585-592.
10. Lasne D, Krenn M, Pingault V, et al. Interdonor variability of platelet response to thrombin receptor activation: influence of PIA2 polymorphism. Br J Haematol. 1997;99:801-807.
11. Dupont A, Fontana P, Bachelot-Loza C, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood. 2003;101:1833-1840.
12. Andre P, Delaney SM, LaRocca T, et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest. 2003;112:398-406.